# A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction

> **NCT05126238** · PHASE3 · TERMINATED · sponsor: **Negovsky Reanimatology Research Institute** · enrollment: 107 (actual)

## Conditions studied

- Carotid Artery Diseases
- Carotid Artery Stenosis

## Interventions

- **DRUG:** Lithium Carbonate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05126238
- **Lead sponsor:** Negovsky Reanimatology Research Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-20
- **Primary completion:** 2025-05-19
- **Final completion:** 2025-05-19
- **Target enrollment:** 107 (ACTUAL)
- **Why stopped:** Decision of the local ethics committee
- **Last updated:** 2025-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05126238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05126238, "A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05126238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*